Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Standard
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. / Oldenburg, Johannes; Klamroth, Robert; Langer, Florian; Albisetti, Manuela; von Auer, Charis; Ay, Cihan; Korte, Wolfgang; Scharf, Rüdiger E; Pötzsch, Bernd; Greinacher, Andreas.
in: HAMOSTASEOLOGIE, Jahrgang 41, Nr. 3, 06.2021, S. 184-189.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
AU - Oldenburg, Johannes
AU - Klamroth, Robert
AU - Langer, Florian
AU - Albisetti, Manuela
AU - von Auer, Charis
AU - Ay, Cihan
AU - Korte, Wolfgang
AU - Scharf, Rüdiger E
AU - Pötzsch, Bernd
AU - Greinacher, Andreas
N1 - Thieme. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
AB - The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).
KW - COVID-19/pathology
KW - COVID-19 Vaccines/administration & dosage
KW - Guidelines as Topic
KW - Heparin/adverse effects
KW - Humans
KW - Purpura, Thrombocytopenic, Idiopathic/diagnosis
KW - Risk Factors
KW - SARS-CoV-2/isolation & purification
KW - Thrombosis/diagnosis
U2 - 10.1055/a-1469-7481
DO - 10.1055/a-1469-7481
M3 - SCORING: Review article
C2 - 33822348
VL - 41
SP - 184
EP - 189
JO - HAMOSTASEOLOGIE
JF - HAMOSTASEOLOGIE
SN - 0720-9355
IS - 3
ER -